Similar articles for PMID: 27064975

Year	Number of Results
1975	1
1981	1
1983	1
1984	1
1985	1
1987	1
1988	2
1989	3
1990	2
1991	6
1992	6
1993	5
1994	5
1995	11
1996	2
1997	5
1998	3
1999	6
2000	3
2001	6
2002	4
2003	7
2004	2
2005	4
2006	7
2007	5
2008	7
2009	10
2010	16
2011	14
2012	18
2013	13
2014	16
2015	20
2016	22
2017	28
2018	22
2019	19
2020	18
2021	24
2022	12
2023	7
2024	0

1

Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.

Launay O, Rosenberg AR, Rey D, Pouget N, Michel ML, Reynes J, Neau D, Raffi F, Piroth L, Carrat F; ANRS HB03 VIHVAC-B (Trial Comparing 3 Strategies of Vaccination Against the Virus of Hepatitis B in HIV-Infected Patients) Group. Launay O, et al. JAMA Intern Med. 2016 May 1;176(5):603-10. doi: 10.1001/jamainternmed.2016.0741. JAMA Intern Med. 2016. PMID: 27064975 Clinical Trial.

2

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.

Launay O, van der Vliet D, Rosenberg AR, Michel ML, Piroth L, Rey D, Colin de Verdière N, Slama L, Martin K, Lortholary O, Carrat F; ANRS HB03 VIHVAC-B Trial. Launay O, et al. JAMA. 2011 Apr 13;305(14):1432-40. doi: 10.1001/jama.2011.351. JAMA. 2011. PMID: 21486976 Clinical Trial.

3

Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.

Rey D, Piroth L, Wendling MJ, Miailhes P, Michel ML, Dufour C, Haour G, Sogni P, Rohel A, Ajana F, Billaud E, Molina JM, Launay O, Carrat F; ANRS HB04 B-BOOST study group. Rey D, et al. Lancet Infect Dis. 2015 Nov;15(11):1283-91. doi: 10.1016/S1473-3099(15)00220-0. Epub 2015 Aug 6. Lancet Infect Dis. 2015. PMID: 26257021 Clinical Trial.

4

Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial.

Chaiwarith R, Praparattanapan J, Kotarathititum W, Wipasa J, Chaiklang K, Supparatpinyo K. Chaiwarith R, et al. AIDS Res Ther. 2019 Nov 11;16(1):33. doi: 10.1186/s12981-019-0249-8. AIDS Res Ther. 2019. PMID: 31711528 Free PMC article. Clinical Trial.

5

Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV: A Randomized Clinical Trial.

Vargas JI, Jensen D, Martínez F, Sarmiento V, Peirano F, Acuña P, Provoste F, Bustos V, Cornejo F, Fuster A, Acuña M, Fuster F, Soto S, Estay D, Jensen W, Ahumada R, Arab JP, Soza A, Fuster F. Vargas JI, et al. JAMA Netw Open. 2021 Aug 2;4(8):e2120929. doi: 10.1001/jamanetworkopen.2021.20929. JAMA Netw Open. 2021. PMID: 34424307 Free PMC article. Clinical Trial.

6

Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression.

Bunupuradah T, Ananworanich J, Pancharoen C, Petoumenos K, Prasitsuebsai W, Wongngam W, Ubolyam S, Sriheara C, Lange J, Phanuphak P, Puthanakit T. Bunupuradah T, et al. Vaccine. 2011 Apr 5;29(16):2962-7. doi: 10.1016/j.vaccine.2011.01.114. Epub 2011 Feb 15. Vaccine. 2011. PMID: 21329776 Clinical Trial.

7

Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.

Potsch DV, Camacho LA, Tuboi S, Villar LM, Miguel JC, Ginuíno C, Silva EF, Mendonça RM, Moreira RB, Barroso PF. Potsch DV, et al. Vaccine. 2012 Sep 7;30(41):5973-7. doi: 10.1016/j.vaccine.2012.07.028. Epub 2012 Jul 21. Vaccine. 2012. PMID: 22828589 Clinical Trial.

8

Comparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: a randomized, controlled trial.

Chaiklang K, Wipasa J, Chaiwarith R, Praparattanapan J, Supparatpinyo K. Chaiklang K, et al. PLoS One. 2013 Nov 12;8(11):e80409. doi: 10.1371/journal.pone.0080409. eCollection 2013. PLoS One. 2013. PMID: 24265819 Free PMC article. Clinical Trial.

9

Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel.

Kalchiem-Dekel O, Grupel D, Bouchnik L, Sikuler E, Ben-Yakov G. Kalchiem-Dekel O, et al. J Gastroenterol Hepatol. 2015 Dec;30(12):1782-7. doi: 10.1111/jgh.13022. J Gastroenterol Hepatol. 2015. PMID: 26101816

10

HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.

O'Bryan TA, Rini EA, Okulicz J, Messner O, Ganesan A, Lalani T, Bavaro MF, O'Connell RJ, Agan BK, Landrum ML. O'Bryan TA, et al. HIV Med. 2015 Mar;16(3):161-7. doi: 10.1111/hiv.12189. Epub 2015 Jan 14. HIV Med. 2015. PMID: 25586899 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

333 results

Results by year